Hunan Tianji Caotang Pharmaceutical Joint-stock Co., Ltd.

Hunan Tianji Caotang Pharmaceutical Joint-stock Co., Ltd. is a high-tech enterprise integrating pharmaceutical R&D, cultivation of traditional Chinese medicinal materials, pharmaceutical production and pharmaceutical sales. The company was established in November 2009 and currently has three production bases. Its headquarters is located in Changsha Lugu High-tech Zone, focusing on the production of Chinese patent medicines; the Zhuzhou production base focuses on the cultivation of traditional Chinese medicinal materials and traditional Chinese medicine extraction; the Changsha Tongguan production base focuses on the production of chemical drugs.
The company's main series of products: heat-clearing and detoxifying category (Qingre Sanjie Capsules, Yanning Capsules, Chuanwang Xiaoyan Capsules, etc.); cardiovascular and cerebrovascular category (Naodesheng Pills, Dengzhanhuasu Tablets, etc.); urological category (Compound Shilintong Capsules, Compound Shiwei Capsules, etc.). Drugs such as Zhangyanming Capsules, Shujin Huoxue Capsules, Huganning Capsules, Danzhi Xiaoyao Tablets, and Ermiao Pills have been included in the National Essential Drugs List and the medical insurance catalog.
The company has always adhered to pharmaceutical research and development, and owns a number of nationally patented products (Zhangyanming Capsules, Shujin Huoxue Capsules, Compound Shiwei Capsules, Fuke Zhidai, etc.). At the same time, new products under research and development, including clopidogrel bisulfate, atorvastatin calcium, moxifloxacin, and fasudil, will be launched successively.
The company has established a complete quality management system, with modern pharmaceutical production workshops and a high-quality, responsible talent team, ensuring the quality of the company's products.
The company adheres to the business philosophy of "determination, integrity, harmony, and choosing goodness," insists on making medicines with "dedication, professionalism, and focus," and strives unremittingly to become a modern pharmaceutical enterprise with industry influence and social visibility.